Non-invasive Serological Monitoring for Crohn's Disease Postoperative Recurrence.

"Conflicts of interest T.D. and A.J. are paid employees of Prometheus Laboratories Inc. No other author has any conflict of interest. Prometheus had no input to the study design, results, or interpretation of data."

"Funding AbbVie, Gutsy Group, Gandel Philanthropy, Angior Foundation, Crohn’s Colitis Australia, and The Australasian Gastro Intestinal Research Foundation [AGIRF] provided funding for the POCER Study. The National Health and Medical Research Council [NHMRC] supported A.L.H., E.K.W., P.D.C., and M.A.K."

"The POCER Study [including this sub-analysis] was approved by the Human Research Ethics Committee of St Vincent’s Hospital, Melbourne [HREC-A 077/09] and was registered with ClinicalTrials.gov [NCT00989560]. All patients provided written informed consent."